Welcome to our dedicated page for BNOW news (Ticker: BNOW), a resource for investors and traders seeking the latest updates and insights on BNOW stock.
News coverage of Boon Industries Inc. (BNOW) tracked developments in the bioscience and chemical disinfection sector, with focus on chlorine dioxide technology applications across agricultural, medical, and industrial markets. Reporting highlighted the company's product launches, manufacturing expansions, regulatory approvals, and market penetration strategies for DiOx+ and BioDox branded solutions.
Media attention centered on facility certifications, production capacity announcements, and customer acquisition milestones as the company commercialized its chlorine dioxide formulations. Coverage examined the company's positioning in disinfection markets, competitive dynamics with established chemical suppliers, and adoption rates among agricultural producers and medical facilities.
Significant news events included the launch of the BioDox product line for commercial agriculture, achievement of cGMP certification for the Grass Valley manufacturing facility, and delivery of initial purchase orders to California agricultural customers. Financial media reported on production capacity expansions, revenue projections, and the company's wholesale pricing structure for concentrated chlorine dioxide products.
In late 2022 and early 2023, coverage shifted to corporate restructuring activities including the acquisition of Cal Care Grp Inc. for $5 million through preferred stock issuance, the appointment of new executive leadership, and plans for business diversification beyond chemical disinfection products. News outlets documented the company's reincorporation from Oklahoma to Florida, name change to CuraScientific Corp., ticker symbol change from BNOW to CSTF, and implementation of a reverse stock split.
Post-restructuring coverage reflected the company's expanded focus on cannabis product manufacturing and distribution under the JW Brands and Chad Enterprises labels, marking a strategic pivot from its original bioscience and chemical disinfection business model. Financial reporting tracked the company's transition through merger completion, leadership changes, and evolving operational priorities across multiple business segments.
Boon Industries, Inc. (OTC: BNOW) has completed the acquisition of Cali Care Grp Inc., enhancing its position in the cannabis distribution market. The transition includes the appointment of William Reed as new CEO and Chairman, who has over two decades of industry experience. The acquisition is projected to increase Boon's revenue, with estimates for 2022 reaching $2M+ from Cali Care Grp, alongside new contracts expected to generate $6M+ in sales. Boon aims to leverage Cali Care's resources to accelerate growth in agricultural distribution.
Boon Industries (OTC: BNOW) has filed its first Annual Report on Form 10-K with the SEC for the year ended December 31, 2021. Highlights include a 25% revenue increase year-on-year, a reduction in stockholders' deficit from $197.7 million to $69.4 million, and a 20% increase in net loss. The company raised $607,000 from financing to support its operations. CEO Justin Gonzalez emphasizes a focus on revenue growth in 2022 and the completion of an expanded production facility to enhance distribution capabilities and create new revenue streams.
Boon Industries, Inc. (OTC PINK: BNOW) has completed its production facility in Grass Valley, gaining a certified Good Manufacturing Practice (cGMP) status. The facility can produce over 1,000 gallons of BioDox per day, generating approximately $300,000 in daily revenue, equating to an annual potential of $78 million. Boon anticipates increased sales due to its cGMP status and aims to penetrate further into agricultural and pending EPA-compliant markets, contributing to ongoing revenue growth.
Boon Industries, Inc. (OTC PINK: BNOW) announced that its Form 10 Registration Statement became effective on February 14, 2022, making it subject to the reporting requirements of the Securities Exchange Act of 1934. This filing provides investors with detailed information, including audited financial statements, improving transparency and investment decisions. CEO Justin Gonzalez views this as a pivotal moment for the company as it enters a new phase of production and transparency. Boon's core product, DiOx+, is a chlorine dioxide disinfectant approved by various regulatory agencies, enhancing its market credibility.
Boon Industries, Inc. (OTC PINK: BNOW) is rolling out a comprehensive marketing effort in Q1 2022, leveraging FIFRA 152.6 and CDPR 25(b) provisions to capitalize on market opportunities. The company anticipates full List-N approval from the EPA soon but can commence sales without it. Boon is fulfilling current purchase orders and boasts expanded manufacturing capacity capable of producing 25,000 cases annually, valued at over $10 million. The BioDox pathogen prevention product targets the $180 million agricultural market, focusing on preventing crop loss, with an optimistic sales approach.
Boon Industries, Inc. (OTC PINK: BNOW) announced its partnership with Wallrich Creative Communications to launch its BioDox products in Q1 2022. Wallrich will assist in developing branding and marketing strategies, leveraging their expertise in healthcare and bioscience sectors. Boon aims to deliver eco-friendly solutions, with its flagship product, DiOx+™, a chlorine dioxide disinfectant approved by leading agencies like OSHA and EPA. This product targets medical equipment sterilization and agricultural protection, following 12 years of global usage.
Boon Industries, Inc. (OTC PINK: BNOW) announced the expansion of its facilities, allowing production of DiOx+ and BioDox at an annual capacity of 25,000 cases, with a potential wholesale value exceeding $10 million. This expansion increases their output by over tenfold compared to previous capabilities. Additionally, the company has enhanced its management and sales team to drive product sales and establish partnerships with industry leaders, aiming to secure a stronger market position in the sterilization and agricultural sectors.
Boon Industries, Inc. (OTC PINK: BNOW) announces the impending completion of its new production facility in Grass Valley, California. This facility will enhance production capacity to approximately 500,000 gallons annually, with operations expected to commence in mid-December 2021. Partnering with A&M Labs allows Boon to improve fulfillment capabilities and expand its product offerings. This strategic move aims to service existing large customers more effectively while also targeting new markets.
Boon Industries, Inc. (OTC: BNOW) announces fulfillment of multiple purchase orders for its new BIODOX product line in California's agricultural sector. BIODOX, a proprietary activated chlorine dioxide solution, is approved by the USDA for organic crop use, targeting food safety. The global agricultural disinfectant market is projected to reach USD $2.1 billion by 2026, growing at a CAGR of 3.5%. Chairman Justin Gonzalez highlights BIODOX's potential to increase agricultural yield and profitability, enhancing food safety standards.
Boon Industries, Inc. (OTC PINK: BNOW) announced the initiation of deliveries of its DiOx+™ products while finalizing regulatory EPA registration. The company has partnered with A&M Labs for processing and packaging, enhancing margins and focusing on distribution. An agreement includes a new lease for warehousing near A&M Labs. Additionally, Mr. Johann Loewen has been appointed as Chief Revenue Officer, aiming to bolster sales oversight. Boon also retired 330,000 shares of Preferred A, valued at $3.3 million, amidst strategic changes. DiOx+ is recognized for its efficacy in disinfecting and sterilization.
FAQ
What is the market cap of BNOW (BNOW)?
